588 related articles for article (PubMed ID: 26644378)
41. Concurrent infection with Heligmosomoides polygyrus modulates murine host response against Plasmodium berghei ANKA infection.
Tetsutani K; Ishiwata K; Torii M; Hamano S; Hisaeda H; Himeno K
Am J Trop Med Hyg; 2008 Dec; 79(6):819-22. PubMed ID: 19052285
[TBL] [Abstract][Full Text] [Related]
42. The Liver-Stage
Sato Y; Ries S; Stenzel W; Fillatreau S; Matuschewski K
Front Immunol; 2019; 10():2554. PubMed ID: 31736970
[TBL] [Abstract][Full Text] [Related]
43. Comparative study of brain CD8+ T cells induced by sporozoites and those induced by blood-stage Plasmodium berghei ANKA involved in the development of cerebral malaria.
Bagot S; Nogueira F; Collette A; do Rosario V; Lemonier F; Cazenave PA; Pied S
Infect Immun; 2004 May; 72(5):2817-26. PubMed ID: 15102792
[TBL] [Abstract][Full Text] [Related]
44. Extracellular vesicles derived from plasmodium-infected red blood cells alleviate cerebral malaria in plasmodium berghei ANKA-infected C57BL/6J mice.
Lv Y; Wu S; Nie Q; Liu S; Xu W; Chen G; Du Y; Chen J
Int Immunopharmacol; 2024 May; 132():111982. PubMed ID: 38569430
[TBL] [Abstract][Full Text] [Related]
45. Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria.
Belnoue E; Potter SM; Rosa DS; Mauduit M; Grüner AC; Kayibanda M; Mitchell AJ; Hunt NH; Rénia L
Parasite Immunol; 2008 Oct; 30(10):544-53. PubMed ID: 18665903
[TBL] [Abstract][Full Text] [Related]
46. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
Brant F; Miranda AS; Esper L; Gualdrón-López M; Cisalpino D; de Souza DDG; Rachid MA; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
Brain Behav Immun; 2016 May; 54():73-85. PubMed ID: 26765997
[TBL] [Abstract][Full Text] [Related]
47. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria.
Yañez DM; Manning DD; Cooley AJ; Weidanz WP; van der Heyde HC
J Immunol; 1996 Aug; 157(4):1620-4. PubMed ID: 8759747
[TBL] [Abstract][Full Text] [Related]
48. Pre-existing Schistosoma japonicum infection alters the immune response to Plasmodium berghei infection in C57BL/6 mice.
Wang ML; Cao YM; Luo EJ; Zhang Y; Guo YJ
Malar J; 2013 Sep; 12():322. PubMed ID: 24034228
[TBL] [Abstract][Full Text] [Related]
49. Unravelling the roles of innate lymphoid cells in cerebral malaria pathogenesis.
Palomo J; Quesniaux VFJ; Togbe D; Reverchon F; Ryffel B
Parasite Immunol; 2018 Feb; 40(2):. PubMed ID: 29117626
[TBL] [Abstract][Full Text] [Related]
50. Splenic CD11c+ cells derived from semi-immune mice protect naïve mice against experimental cerebral malaria.
Bao LQ; Nhi DM; Huy NT; Kikuchi M; Yanagi T; Hamano S; Hirayama K
Malar J; 2015 Jan; 14():23. PubMed ID: 25626734
[TBL] [Abstract][Full Text] [Related]
51. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling.
Claser C; De Souza JB; Thorburn SG; Grau GE; Riley EM; Rénia L; Hafalla JCR
Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396319
[TBL] [Abstract][Full Text] [Related]
52. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
Keswani T; Bhattacharyya A
Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
[TBL] [Abstract][Full Text] [Related]
53. VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.
Canavese M; Dottorini T; Crisanti A
Pathog Glob Health; 2015 Sep; 109(6):255-65. PubMed ID: 26392042
[TBL] [Abstract][Full Text] [Related]
54. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y
Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
[TBL] [Abstract][Full Text] [Related]
55. Gamma delta T-cell function in pathogenesis of cerebral malaria in mice infected with Plasmodium berghei ANKA.
Yañez DM; Batchelder J; van der Heyde HC; Manning DD; Weidanz WP
Infect Immun; 1999 Jan; 67(1):446-8. PubMed ID: 9864254
[TBL] [Abstract][Full Text] [Related]
56. Co-infection with Trypanosoma cruzi protects mice against early death by neurological or pulmonary disorders induced by Plasmodium berghei ANKA.
Egima CM; Macedo SF; Sasso GR; Covarrubias C; Cortez M; Maeda FY; Costa FT; Yoshida N
Malar J; 2007 Jul; 6():90. PubMed ID: 17620126
[TBL] [Abstract][Full Text] [Related]
57. Protection of Batf3-deficient mice from experimental cerebral malaria correlates with impaired cytotoxic T-cell responses and immune regulation.
Kuehlwein JM; Borsche M; Korir PJ; Risch F; Mueller AK; Hübner MP; Hildner K; Hoerauf A; Dunay IR; Schumak B
Immunology; 2020 Feb; 159(2):193-204. PubMed ID: 31631339
[TBL] [Abstract][Full Text] [Related]
58. Perivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral Malaria.
Shaw TN; Stewart-Hutchinson PJ; Strangward P; Dandamudi DB; Coles JA; Villegas-Mendez A; Gallego-Delgado J; van Rooijen N; Zindy E; Rodriguez A; Brewer JM; Couper KN; Dustin ML
PLoS Pathog; 2015; 11(11):e1005210. PubMed ID: 26562533
[TBL] [Abstract][Full Text] [Related]
59. Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.
Schmidt KE; Kuepper JM; Schumak B; Alferink J; Hofmann A; Howland SW; Rénia L; Limmer A; Specht S; Hoerauf A
PLoS One; 2018; 13(2):e0192717. PubMed ID: 29438386
[TBL] [Abstract][Full Text] [Related]
60. IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells.
Besnard AG; Guabiraba R; Niedbala W; Palomo J; Reverchon F; Shaw TN; Couper KN; Ryffel B; Liew FY
PLoS Pathog; 2015 Feb; 11(2):e1004607. PubMed ID: 25659095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
